Furthermore, the Keap1-Nrf2-SOD pathway showed that T-MSCs can upregulate the expression of the antioxidant enzymes SOD-1 and SOD-2, and increase nuclear Nrf2 expression, further enhancing the antioxidant ability of PD. The gene discussed is SOD2; the disease is Parkinson disease.